title: eIF4A1 is a promising new therapeutic target in ER-negative breast cancer.
authors.affiliation: MRC Toxicology Unit, Hodgkin Building, Lancaster Road, Leicester LE1 9HN, UK.
authors.forename: M
authors.initials: M
authors.lastname: Stoneley
authors.affiliation: MRC Toxicology Unit, Hodgkin Building, Lancaster Road, Leicester LE1 9HN, UK.
authors.forename: A E
authors.initials: AE
authors.lastname: Willis
mesh_terms: D001943:Breast Neoplasms / Q000378:metabolism* / Q000473:pathology*; D039601:Eukaryotic Initiation Factor-4A / Q000378:metabolism*; D005260:Female; D006801:Humans; D014176:Protein Biosynthesis
chemical_list: D039601:Eukaryotic Initiation Factor-4A